ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Funding Opportunities
Grants.govNational Institutes of Health

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Posted Sep 1, 2026·open

AGENCY

HHS-NIH11

PROGRAM

Discretionary

AMOUNT

—

CLOSES

Oct 9, 2028

Description

The purpose of this notice of funding opportunity (NOFO) is to support research that advances understanding of the natural history of radiation or chemical exposures; develops relevant injury models; identifies and validates diagnostic tools, biomarkers, or triage technologies; and supports the development of effective medical countermeasures (MCMs) to mitigate or treat acute and/or delayed injuries resulting from radiological/nuclear or chemical public health emergencies.

Eligibility

Private institutions of higher education; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Small businesses; State governments; Public housing authorities/Indian housing authorities; City or township governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); County governments; Public and State controlled institutions of higher education; Independent school districts; Native American tribal governments (Federally recognized)

Contact

National Institutes of Health

RADCHEM_U01@mail.nih.gov

301-402-2541

Additional details

Funding instrument
Cooperative Agreement
Cost sharing required
No
Archived
Dec 8, 2028

Opportunity number: RFA-AI-27-014

Search this number on Grants.gov for the official listing.